Post by Alnylam Pharmaceuticals

290,476 followers

That's a wrap on #PNS2026! Thank you to the neurology community for a week of meaningful discussion and exchange. We’re encouraged by the continued focus on earlier recognition and intervention in hereditary transthyretin #amyloidosis with polyneuropathy (hATTR-PN) and appreciated connecting with those dedicated to improving outcomes for patients.

Post content

Video Content